Gary A Weisman (G A Weisman)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Disease Activity

Top Venues

Purinergic signalling

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Zainab Assy, William Murray Thomson, Henk S Brand, Seunghee Cha, Merve M Susam, Gary A Weisman, Arjan Vissink, Floris J Bikker, Derk Hendrik Jan Jager
The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients. Oral diseases (2023)
Zainab Assy, William Murray Thomson, Henk S Brand, Seunghee Cha, Merve M Susam, Gary A Weisman, Arjan Vissink, Floris J Bikker, Derk Hendrik Jan Jager
The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients. Oral diseases (2023)
Zainab Assy, William Murray Thomson, Henk S Brand, Seunghee Cha, Merve M Susam, Gary A Weisman, Arjan Vissink, Floris J Bikker, Derk Hendrik Jan Jager
The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients. Oral diseases (2023)
Kimberly J Jasmer, Kevin Muñoz Forti, Lucas T Woods, Seunghee Cha, Gary A Weisman
Therapeutic potential for P2Y 2 receptor antagonism. Purinergic signalling (2022)
Austin N Spratt, Saathvik R Kannan, Lucas T Woods, Gary A Weisman, Thomas P Quinn, Christian L Lorson, Anders Sönnerborg, Siddappa N Byrareddy, Kamalendra Singh
Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants. bioRxiv : the preprint server for biology (2021)
L T Woods, J M Camden, M G Khalafalla, M J Petris, L Erb, J L Ambrus, Gary A Weisman
P2Y2 R deletion ameliorates sialadenitis in IL-14α-transgenic mice. Oral diseases 24 (5) (2018)